Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Refractory Systemic Vasculitis.

Laisvyde Statkute, MD, Yu Oyama, MD, Walter G. Barr, MD, Jolita Satkus, MD, Yvonne Loh, MD, Larissa Verda, MD, PhD, Richard K. Burt, MD

Blood (2006) 108 (11): 5457.

https://doi.org/10.1182/blood.V108.11.5457.5457

Published: 2006

Journal Articles

Prevalence and Reversibility of Cardiac Dysfunction in Systemic Lupus Erythematosus: Improved Ventricular and Valvular Function after Disease Remission Following Hematopoietic Stem Cell Transplantation.

Yvonne Loh, MD, Yu Oyama, MD, Laisvyde Statkute, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Walter Barr, MD, Jurate Bucha, MD, Richard K. Burt, MD

Blood (2006) 108 (11): 5423.

https://doi.org/10.1182/blood.V108.11.5423.5423

Published: 2006

Journal Articles

Immune Dysregulation after Hematopoietic Stem Cell Transplantation for Autoimmune Diseases Leading to Development of a Second Autoimmune Disorder: Role of Conditioning Regimen Used?.

Yvonne Loh, MD, Yu Oyama, MD, Laisvyde Statkute, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Walter Barr, MD, Richard K. Burt, MD

Blood (2006) 108 (11): 760.

https://doi.org/10.1182/blood.V108.11.760.760

Published: 2006

Journal Articles

Mobilization, Harvesting and Selection of Peripheral Blood Stem Cells in Patients with Autoimmune Diseases Undergoing Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation.

Laisvyde Statkute, MD, Larissa Verda, MD, PhD, Yu Oyama, MD, Marcelo Villa, Thomas Shook, Ronnie Clifton, Nela Krosnjar, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Catherine Weppner, RN, Richard K. Burt, MD

Blood (2005) 106 (11): 1980.

https://doi.org/10.1182/blood.V106.11.1980.1980

Published: 2005

Journal Articles

Restoration of the CD4+CD25 bright Regulatory Cell Subset in Patients with Crohn’s Disease Following Autologous Non-Myeloablative Stem Cell Transplantation (NST).

Larissa Verda, MD, PhD, Yu Oyama, MD, Robert Craig, MD, Laisvyde Statkute, MD, Nela Krosnjar, MD, Kathleen Quigley, RN, Richard K. Burt, MD

Blood (2005) 106 (11): 2193.

https://doi.org/10.1182/blood.V106.11.2193.2193

Published: 2005

Journal Articles

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Richard K. Burt, MD, Yu Oyama, MD, Laisvyde Statkute, MD, Kathleen Quigley, RN, Catherine Weppner, RN, Larissa Verda, MD, PhD

Blood (2005) 106 (11): 2930.

https://doi.org/10.1182/blood.V106.11.2930.2930

Published: 2005

Journal Articles

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.

Laisvyde Statkute, MD, Yu Oyama, MD, Ann Traynor, MD, Larissa Verda, MD, PhD, Walter G. Barr, MD, Robert Rosa, MD, James Schroeder, MD, Nela Krosnjar, MD, Kathleen Quigley, RN, Kimberly Yaung, RN, Marcelo Villa, Miyuki Takahashi, MD, Richard K. Burt, MD

Blood (2005) 106 (11): 156.

https://doi.org/10.1182/blood.V106.11.156.156

Published: 2005

Journal Articles

An Edible, High Molecular Weight Glycoprotein Fraction from Ganoderma Lucidum Inhibits the Akt Pathway in Resistant Myeloma Cell Lines Decreasing Mcl-1 Expression, Up-Regulating FKHR and Inducing Apoptosis.

Nazneen Sultana, MD, Larissa Verda, MD, Richard K. Burt, MD, Ann E. Traynor, MD

Blood (2004) 104 (11): 4895.

https://doi.org/10.1182/blood.V104.11.4895.4895

Published: 2004

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus.

Julio C. Voltarelli, MD PhD, Carlos E.B. Couri, MD, Maria-Carolina B. Oliveira, MD, Ana-Beatriz P.L. Stracieri, MD PhD, Daniela A. Moraes, MD, Dannielle F. Godoi, MD, Marina A. Coutinho, MD MsC, Kelen C.R. Malmegrim, BsC, Maria-Cristina Foss-Freitas, MD, Milton C. Foss, MD PhD, Belinda P. Simoes, MD PhD, Elizabeth C. Squiers, MD, Richard K. Burt, MD

Blood (2004) 104 (11): 5224.

https://doi.org/10.1182/blood.V104.11.5224.5224

Published: 2004

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation without Total Body Irradiation for Diffuse Scleroderma. Rapid Improvement of Skin Score.

Yu Oyama, MD, Richard K. Burt, MD, Ann E. Traynor, MD, Laisvyde Statkute, MD, Walter G. Barr, MD

Blood (2004) 104 (11): 5195.

https://doi.org/10.1182/blood.V104.11.5195.5195

Published: 2004

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Refractory Systemic Vasculitis Involving Central Nervous System.

Yu Oyama, MD, Richard K. Burt, MD, Ann E. Traynor, MD, Laisvyde Statkute, MD, Kathleen A. Quigley, RN, Kimberly Yaung, RN, Mary Brush, RN, Walter G. Barr, MD

Blood (2004) 104 (11): 5240.

https://doi.org/10.1182/blood.V104.11.5240.5240

Published: 2004

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe and Refractory Crohn’s Disease.

Yu Oyama, MD, Robert M. Craig, MD, Ann E. Traynor, MD, Richard K. Burt, MD, Laisvyde Statkute, MD

Blood (2004) 104 (11): 1874.

https://doi.org/10.1182/blood.V104.11.1874.1874

Published: 2004

NARROW

Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Refractory Systemic Vasculitis.

Prevalence and Reversibility of Cardiac Dysfunction in Systemic Lupus Erythematosus: Improved Ventricular and Valvular Function after Disease Remission Following Hematopoietic Stem Cell Transplantation.

Immune Dysregulation after Hematopoietic Stem Cell Transplantation for Autoimmune Diseases Leading to Development of a Second Autoimmune Disorder: Role of Conditioning Regimen Used?.

Mobilization, Harvesting and Selection of Peripheral Blood Stem Cells in Patients with Autoimmune Diseases Undergoing Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation.

Restoration of the CD4+CD25 bright Regulatory Cell Subset in Patients with Crohn’s Disease Following Autologous Non-Myeloablative Stem Cell Transplantation (NST).

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Relapsing-Remitting Multiple Sclerosis.

Non-Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.

An Edible, High Molecular Weight Glycoprotein Fraction from Ganoderma Lucidum Inhibits the Akt Pathway in Resistant Myeloma Cell Lines Decreasing Mcl-1 Expression, Up-Regulating FKHR and Inducing Apoptosis.

Autologous Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus.

Autologous Hematopoietic Stem Cell Transplantation without Total Body Irradiation for Diffuse Scleroderma. Rapid Improvement of Skin Score.

Autologous Hematopoietic Stem Cell Transplantation in Refractory Systemic Vasculitis Involving Central Nervous System.

Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe and Refractory Crohn’s Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only